Improvement of (transition metal-modified) activated carbon regeneration by H2O2-promoted catalytic wet air oxidation

Oxidative regeneration of activated carbon (AC) exhausted with phenolic compounds is still a challenging issue due to the frequent porosity loss. Addition of low H2O2 amount is investigated as a way to promote catalytic wet air oxidation (CWAO) of adsorbed pollutants and thereby to recover absorbent...

Description complète

Détails bibliographiques
Publié dans:Environmental technology. - 1993. - 39(2018), 21 vom: 17. Nov., Seite 2761-2770
Auteur principal: Benhamed, Imane (Auteur)
Autres auteurs: Barthe, Laurie, Kessas, Rachid, Delmas, Henri, Julcour, Carine
Format: Article en ligne
Langue:English
Publié: 2018
Accès à la collection:Environmental technology
Sujets:Journal Article Wastewater treatment adsorption advanced oxidation phenol sequential process Water Pollutants, Chemical Charcoal 16291-96-6 Carbon plus... 7440-44-0 Hydrogen Peroxide BBX060AN9V
Description
Résumé:Oxidative regeneration of activated carbon (AC) exhausted with phenolic compounds is still a challenging issue due to the frequent porosity loss. Addition of low H2O2 amount is investigated as a way to promote catalytic wet air oxidation (CWAO) of adsorbed pollutants and thereby to recover absorbent properties. Commercial AC and transition metal (iron or copper)-modified counterparts are tested in repeated adsorption/batch peroxide-promoted CWAO of phenol. Cycles are operated in both fixed bed and slurry reactors to vary the initial pollutant distribution in between the two phases. Influence of metal location is also studied by adding iron salt to the pollutant solution prior to perform peroxide-promoted oxidation on bare carbon. Regeneration results are analyzed through a detailed analysis of both the solid and the liquid phases during the oxidative treatment. It is proved that a convenient H2O2 dosage can increase the lifetime of adsorbent in adsorption-oxidation cycles, but coupling with (un)supported metal oxide does not provide significant gain
Description:Date Completed 09.09.2019
Date Revised 09.09.2019
published: Print-Electronic
Citation Status MEDLINE
ISSN:1479-487X
DOI:10.1080/09593330.2017.1365942